Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Classement en actions #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Prix de l'action
$0.03808538
Capitalisation boursière
$14.04M
Changement (1 jour)
-3.57%
Changement (1 an)
6.63%
Pays
AU
Échange BCAL Diagnostics Limited (BDX)

Catégorie

Historique du prix de l'action pour BCAL Diagnostics Limited (BDX)
Prix de clôture le plus élevé : $0.04 le 2026-08-01

Prix de clôture le plus bas : $0.15 le 2021-07-01
Historique du prix de l'action de BCAL Diagnostics Limited de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -14.06%
2025 6.49%
2024 -5.30%
2023 59.08%
2022 -54.80%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$587.66 20.54%
US
$200.35 -4.14%
US
$24.23 79.49%
CN
$313.63 94.62%
US
$556.25 -12.80%
US